NCT06883474CompletedNot Applicable
Osteosclerotic Changes on Computed Tomography Predict Disease Progression and Poor Survival in Prostate Cancer
Sun Yat-sen University0 sites211 target enrollmentStarted: July 1, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 211
- Primary Endpoint
- Radiographic progression-free survival
Study Overview
Brief Summary
The study specifically investigated PC patients with bone metastasis and conducted a comprehensive analysis of the correlation between OCs and patient survival outcomes.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •1)Histopathological confirmation of prostate adenocarcinoma
- •2)Radiologically verified bone metastasis, assessed through bone scintigraphy and CT imaging from the initiation of systemic therapy until disease progression.
Exclusion Criteria
- •1)Lacking of complete clinical profiles.
Outcomes
Primary Outcomes
Radiographic progression-free survival
Time Frame: From enrollment to the end of treatment at 5 years
Secondary Outcomes
- overall survival(From enrollment to the end of treatment at 5 years)
Investigators
Meiting Chen
Doctor
Sun Yat-sen University
Similar Trials
Unknown
Not Applicable
The Role of Bone SPECT/CT in Evaluation of Persistent or Recurrent Back Pain Following Spine SurgerySpine FusionNCT04803136Assiut University4
Completed
Not Applicable
Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.Bone MetastasesNCT04080271Assiut University66
Unknown
Not Applicable
Diagnostic Imaging of Bone Metastases in Prostate Cancer PatientsProstate Cancer Metastatic to BoneNCT03134261Herlev Hospital300
Completed
Not Applicable
Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)Cervical Disc Degenerative DisorderNCT02182843Zimmer Biomet81
Completed
Early Phase 1
C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate CancerProstate Cancer PatientsNCT02715583Abramson Cancer Center at Penn Medicine6
